RE:RE:RE:RE:RE:RE:RE:RE:Don’t ignore the Bashers…Don't get me wrong Gorf, I place the probablity of success at MUCH higher than 50%...
...mainly because, as you say, they pretty much tick (as you point out) all the boxes of BTD
...but also becasue Baxter is involved, and ...
...also because under Tigris, they are "greatly exceeding expectations", and also
...because ther have been more than 200,000 safe uses , and also because
...the world's leading KOL's are all behind HP, and because
...there is an accompanying FDA approved companion diagnostic (in the EAA) , and its now all about Precision Medicine.
..and becasue they got almost unheard of breaks for the "confirmatory Trial" (2:1, Bayesian, Open Label, etc.)
..and becasue they know exactly where it is most effective (from trials 1 to 3, as well as from other Meta Analyses)
I may not be at 100% as you are, but it's alot closer to that for me now. And of course they have the "other" trick pony, banging at the stall wall to get out (where FDA approval of DIMI for home use, is described as a "when, not if" event - by the CEO).
So the "gap" is beyond ridiculous IMHO.
MM